-
Poss Double Good News
Not only is there a drug [ibudilast (MN-166)] in testing that reduces MS inflammation. There’s now a non-invasive optical [optical coherence tomography (OCT)] method to measure it it! It may even be triple good news as it works on progressive MS.
Our news section reports this in the article embedded here.
I can no longer jump for joy but I am metaphorically.
Does this development also cheer u up?
Log in to reply.